Osmind is a public-benefit corporation (PBC) that assists mental health clinics with software in the treatment of depression, mostly with psychedelics (ketamine).
Osmind
Osmind also hosts a community for patients on its website.
The company serves 135 clinics and over 22,000 patients. It is backed by Y Combinator and General Catalyst.
As of May 2022, Osmind has raised a total of $57.2M in funding over 4 rounds. Their latest funding was raised in a Series B round and led by DFJ Growth.
“As a Public Benefit Corporation (PBC), we are committed to improving mental health care for those who need it most. We remain unwavering in our service of people with treatment-resistant depression and related mental health issues.”
Media
- Dr. Robin Carhart-Harris Joins Osmind as a Scientific Advisor (press release, February 2021)
- Lucia Huang – Using Software to improve Psychedelic Therapy (Mind Things podcast, November 2020)
Activities
B2B
B2C
Digital Health / Software / App
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates